Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by 2quick154on Feb 21, 2018 12:52pm
161 Views
Post# 27595057

RE:RE:RE:Tip of the Hat to management & BOD

RE:RE:RE:Tip of the Hat to management & BODI may sell some at $4, but no.. I can wait it out for much higher SP.  Agree 100 % with your assessment of the pipeline... but there is nothing that would warrant a $10 share price or roughly a $8 Billion market cap this year, except a buyout, which won’t happen.

No, their thought is not that we should be at $10 US when we have no cash in the bank.  They have asked managment why we are not trading at similiar levels as FGEN and GLGP and the answer is because we have no partnerships and no money.

Guys, if we list on Nasdaq were not going to shoot up to $10 a share - they have to deliver and IMO The jury is still out on that one.
Bullboard Posts